Tumor-Targeting Polycaprolactone Nanoparticles with Codelivery of Paclitaxel and IR780 for Combinational Therapy of Drug-Resistant Ovarian Cancer.
第一作者:
Qianqian,Pan
第一单位:
Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, P. R. China.;Zhejiang Financial College, No. 118 Xueyuan Street, Hangzhou, Zhejiang 310018, P. R. China.
作者:
主题词
抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);细胞系, 肿瘤(Cell Line, Tumor);女(雌)性(Female);人类(Humans);纳米粒子(Nanoparticles);卵巢肿瘤(Ovarian Neoplasms);紫杉酚(Paclitaxel);药用制剂(Pharmaceutical Preparations);多酯类(Polyesters);聚乙烯二醇类(Polyethylene Glycols)
DOI
10.1021/acsbiomaterials.0c00163
PMID
33455308
发布时间
2021-05-10
- 浏览0

ACS biomaterials science & engineering
2020年6卷4期
2175-2185页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文